Esperion Therapeutics, Inc.

The current price of ESPR is 1.91 USD — it has decreased by 1.29% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Esperion Therapeutics, Inc. stocks are traded under the ticker ESPR.

Esperion Therapeutics, Inc. is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.

One year price forecast for Esperion Therapeutics, Inc. has a max estimate of 16.00 USD and a min estimate of 2.90 USD.

ESPR earnings for the last quarter are −0.37 USD whereas the estimation was −0.43 USD which accounts for 13.56% surprise. Estimated earnings for the next quarter are −0.48 USD. See more details about Esperion Therapeutics, Inc. earnings.

Yes, you can track Esperion Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.

Like other stocks, ESPR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Esperion Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.

ESPR reached its all-time high on May 21, 2015 with the price of 120.96 USD, and its all-time low was 0.70 USD and was reached on Oct 12, 2023.
See other stocks reaching their highest and lowest prices.

As of Apr 16, 2024, the company has 240.00 employees. See our rating of the largest employees — is Esperion Therapeutics, Inc. on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Esperion Therapeutics, Inc. EBITDA is ‪−142.30 M‬ USD, and current EBITDA margin is −133.58%. See more stats in Esperion Therapeutics, Inc. financial statements.